TAVIS DANCIK

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ROYAL OAK, MI NPI 1396971263

General Payments — all program years on this page

$5,016.97

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 240
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $366.28 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $325.0014
Education $41.282

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $924.6039
2019 $810.1535
2020 $408.3715
2021 $560.1733
2022 $1,014.7057
2023 $932.7045
2024 $366.2816

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086925117 Novartis Pharmaceuticals Corporation $22.43 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091135653 ANI Pharmaceuticals, Inc. $22.17 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093894675 Alexion Pharmaceuticals, Inc. $17.64 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843808 OPKO Pharmaceuticals, LLC $16.67 05/21/2024 Education Undisputed 01/23/2026 View at CMS
1115549263 Amgen Inc. $30.61 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115549273 Amgen Inc. $19.91 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135448775 Lilly USA, LLC $25.06 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145061502 Mallinckrodt Hospital Products Inc. $24.25 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145061506 Mallinckrodt Hospital Products Inc. $25.08 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145833823 AKEBIA THERAPEUTICS INC $24.61 10/23/2024 Education Undisputed 01/23/2026 View at CMS
1146677074 Ardelyx, Inc. $24.07 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146677076 Ardelyx, Inc. $25.77 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149878896 Travere Therapeutics, Inc. $5.80 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150678813 Aurinia Pharma U.S., Inc. $29.87 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150678815 Aurinia Pharma U.S., Inc. $24.78 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150678817 Aurinia Pharma U.S., Inc. $27.56 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.